Public health expert Céline Gounder, KFF Health News’ editor-at-large for public health, discussed several significant health topics on CBS News in early June 2026. She reviewed new findings relating ultraprocessed foods to increased dementia risk, updates on the Ebola outbreak in central Africa, and research linking GLP-1 drugs to lower breast cancer rates.
What Happened
On June 3, Gounder appeared on CBS News 24/7’s The Daily Report to discuss a recent study suggesting a link between ultraprocessed food consumption and increased risk of dementia. That same day, she also spoke on CBS Mornings about the ongoing Ebola outbreak in central Africa and the consequences of U.S. cuts to health funding. On June 2, she addressed findings from a study that reported women using GLP-1 drugs had a decreased incidence of breast cancer, also on CBS Mornings. Earlier, on June 1, she commented on President Donald Trump’s updated medical report and the role of creatine supplements in health during CBS News broadcasts.
Key Facts
- The dementia study linking ultraprocessed foods to increased risk was the main focus of Gounder’s June 3 discussion on The Daily Report.
- The Ebola outbreak affects central Africa, with discussions highlighting how U.S. health funding reductions might impact containment efforts.
- The GLP-1 drug study, discussed on June 2, indicated lower breast cancer diagnoses among women taking these medications.
- Céline Gounder is KFF Health News’ editor-at-large for public health, representing an established health journalism organization.
Why It Matters
The connections between diet, emerging infectious diseases, and medication effects on cancer incidence have significant implications for public health strategies. Understanding potential dementia risks from ultraprocessed foods could lead to new dietary guidelines, while awareness of Ebola outbreak dynamics informs global health responses. The GLP-1 drug findings may influence clinical decision-making regarding breast cancer prevention among patients using these treatments.
Background
Prior research has examined the health impacts of ultraprocessed food consumption and its association with chronic diseases. The Ebola virus continues to pose outbreak challenges in central Africa, with fluctuating global attention and funding. GLP-1 receptor agonists, initially developed for diabetes management, have more recently been studied for diverse health effects, including potential cancer risk reduction.
Analysis
Céline Gounder provided expert commentary contextualizing these developments within the broader public health landscape, emphasizing the importance of funding and evidence-based evaluation of emerging studies and health trends. She highlighted the need to consider systemic factors, such as funding cuts, that may undermine outbreak control and overall health outcomes.
Who Is Affected
- Central African populations facing the Ebola outbreak.
- Individuals consuming high levels of ultraprocessed foods globally.
- Women taking GLP-1 drugs for diabetes or other indications.
- U.S. public health funding bodies and global health partnerships.
What Remains Unclear
- The reviewed information did not confirm specific sample sizes or statistical details for the ultraprocessed food and dementia study.
- The precise impact of U.S. funding cuts on Ebola outbreak containment outcomes remains to be fully determined.
- The GLP-1 breast cancer study’s mechanisms and long-term clinical applicability require further investigation.
What Comes Next
This information was not confirmed in the reviewed sources.
Sources
This article is based on reporting and publicly available information from the following source:
Read more Health & Public Health stories on Goka World News.